{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,3]],"date-time":"2026-10-03T23:02:28Z","timestamp":1791068548960,"version":"4.1.0"},"reference-count":71,"publisher":"Elsevier BV","issue":"7","license":[{"start":{"date-parts":[[2019,9,1]],"date-time":"2019-09-01T00:00:00Z","timestamp":1567296000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2019,9,1]],"date-time":"2019-09-01T00:00:00Z","timestamp":1567296000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","jaci-inpractice.org","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["The Journal of Allergy and Clinical Immunology: In Practice"],"published-print":{"date-parts":[[2019,9]]},"DOI":"10.1016\/j.jaip.2019.05.034","type":"journal-article","created":{"date-parts":[[2019,9,5]],"date-time":"2019-09-05T05:42:33Z","timestamp":1567662153000},"page":"2116-2123","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":81,"title":["Sulfonamide Hypersensitivity: Fact and Fiction"],"prefix":"10.1016","volume":"7","author":[{"given":"David A.","family":"Khan","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sandra R.","family":"Knowles","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Neil H.","family":"Shear","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.jaip.2019.05.034_bib1","doi-asserted-by":"crossref","first-page":"1305","DOI":"10.1111\/all.12881","article-title":"Drug allergies documented in electronic health records of a large healthcare system","volume":"71","author":"Zhou","year":"2016","journal-title":"Allergy"},{"key":"10.1016\/j.jaip.2019.05.034_bib2","doi-asserted-by":"crossref","first-page":"239","DOI":"10.2165\/00002018-200124040-00001","article-title":"Should celecoxib be contraindicated in patients who are allergic to sulfonamides? Revisiting the meaning of 'sulfa' allergy","volume":"24","author":"Knowles","year":"2001","journal-title":"Drug Saf"},{"key":"10.1016\/j.jaip.2019.05.034_bib3","doi-asserted-by":"crossref","first-page":"1347","DOI":"10.1016\/0161-5890(88)90050-8","article-title":"Drugs as allergens: detection and combining site specificities of IgE antibodies to sulfamethoxazole","volume":"25","author":"Harle","year":"1988","journal-title":"Mol Immunol"},{"issue":"Pt 1","key":"10.1016\/j.jaip.2019.05.034_bib4","doi-asserted-by":"crossref","first-page":"1017","DOI":"10.1016\/0091-6749(94)90120-1","article-title":"Immunochemical analysis of sulfonamide drug allergy: identification of sulfamethoxazole-substituted human serum proteins","volume":"94","author":"Meekins","year":"1994","journal-title":"J\u00a0Allergy Clin Immunol"},{"key":"10.1016\/j.jaip.2019.05.034_bib5","doi-asserted-by":"crossref","first-page":"179","DOI":"10.7326\/0003-4819-105-2-179","article-title":"Differences in metabolism of sulfonamides predisposing to idiosyncratic toxicity","volume":"105","author":"Shear","year":"1986","journal-title":"Ann Intern Med"},{"key":"10.1016\/j.jaip.2019.05.034_bib6","doi-asserted-by":"crossref","first-page":"406","DOI":"10.1016\/S0090-9556(25)06552-3","article-title":"N4-hydroxylation of sulfamethoxazole by cytochrome P450 of the cytochrome P4502C subfamily and reduction of sulfamethoxazole hydroxylamine in human and rat hepatic microsomes","volume":"23","author":"Cribb","year":"1995","journal-title":"Drug Metab Dispos"},{"key":"10.1016\/j.jaip.2019.05.034_bib7","doi-asserted-by":"crossref","first-page":"900","DOI":"10.1016\/S0090-9556(25)08967-6","article-title":"Reactions of the nitroso and hydroxylamine metabolites of sulfamethoxazole with reduced glutathione. Implications for idiosyncratic toxicity","volume":"19","author":"Cribb","year":"1991","journal-title":"Drug Metab Dispos"},{"key":"10.1016\/j.jaip.2019.05.034_bib8","doi-asserted-by":"crossref","first-page":"1393","DOI":"10.1038\/sj.bjp.0702453","article-title":"Cellular disposition of sulphamethoxazole and its metabolites: implications for hypersensitivity","volume":"126","author":"Naisbitt","year":"1999","journal-title":"Br J Pharmacol"},{"key":"10.1016\/j.jaip.2019.05.034_bib9","doi-asserted-by":"crossref","first-page":"856","DOI":"10.1592\/phco.24.9.856.36106","article-title":"Likelihood and mechanisms of cross-allergenicity between sulfonamide antibiotics and other drugs containing a sulfonamide functional group","volume":"24","author":"Brackett","year":"2004","journal-title":"Pharmacotherapy"},{"key":"10.1016\/j.jaip.2019.05.034_bib10","doi-asserted-by":"crossref","first-page":"354","DOI":"10.1016\/j.amjmed.2005.10.052","article-title":"Is there cross-reactivity between penicillins and cephalosporins?","volume":"119","author":"Apter","year":"2006","journal-title":"Am J Med"},{"key":"10.1016\/j.jaip.2019.05.034_bib11","doi-asserted-by":"crossref","first-page":"1628","DOI":"10.1056\/NEJMoa022963","article-title":"Absence of cross-reactivity between sulfonamide antibiotics and sulfonamide nonantibiotics","volume":"349","author":"Strom","year":"2003","journal-title":"N\u00a0Engl J Med"},{"key":"10.1016\/j.jaip.2019.05.034_bib12","doi-asserted-by":"crossref","first-page":"2065","DOI":"10.1016\/S0149-2918(00)87238-0","article-title":"Immunologic tolerability profile of celecoxib","volume":"21","author":"Patterson","year":"1999","journal-title":"Clin Ther"},{"key":"10.1016\/j.jaip.2019.05.034_bib13","doi-asserted-by":"crossref","first-page":"196","DOI":"10.1111\/jcpt.12048","article-title":"An evidence-based approach for providing cautionary recommendations to sulfonamide-allergic patients and determining cross-reactivity among sulfonamide-containing medications","volume":"38","author":"Ghimire","year":"2013","journal-title":"J\u00a0Clin Pharm Ther"},{"key":"10.1016\/j.jaip.2019.05.034_bib14","doi-asserted-by":"crossref","first-page":"1483","DOI":"10.2146\/ajhp120291","article-title":"Sulfonamide cross-reactivity: is there evidence to support broad cross-allergenicity?","volume":"70","author":"Wulf","year":"2013","journal-title":"Am J Health Syst Pharm"},{"key":"10.1016\/j.jaip.2019.05.034_bib15","doi-asserted-by":"crossref","first-page":"187","DOI":"10.2165\/00002018-200326030-00004","article-title":"Safety of celecoxib in individuals allergic to sulfonamide: a pilot study","volume":"26","author":"Shapiro","year":"2003","journal-title":"Drug Saf"},{"key":"10.1016\/j.jaip.2019.05.034_bib16","doi-asserted-by":"crossref","first-page":"456","DOI":"10.1089\/jop.2012.0123","article-title":"Evaluation of adverse events in self-reported sulfa-allergic patients using topical carbonic anhydrase inhibitors","volume":"29","author":"Guedes","year":"2013","journal-title":"J\u00a0Ocul Pharmacol Ther"},{"key":"10.1016\/j.jaip.2019.05.034_bib17","doi-asserted-by":"crossref","first-page":"866","DOI":"10.2214\/AJR.17.18801","article-title":"Safety of administering furosemide during nuclear diuretic renography in patients with sulfonamide allergies","volume":"210","author":"Wang","year":"2018","journal-title":"AJR Am J Roentgenol"},{"key":"10.1016\/j.jaip.2019.05.034_bib18","doi-asserted-by":"crossref","first-page":"2213","DOI":"10.1097\/QAD.0000000000000835","article-title":"Clinical relevance of cross-reactivity between darunavir and trimethoprim-sulfamethoxazole in HIV-infected patients","volume":"29","author":"Lin","year":"2015","journal-title":"AIDS"},{"key":"10.1016\/j.jaip.2019.05.034_bib19","doi-asserted-by":"crossref","first-page":"831","DOI":"10.1016\/j.jaip.2016.11.011","article-title":"Dapsone is often tolerated in HIV-infected patients with history of sulfonamide antibiotic intolerance","volume":"5","author":"May","year":"2017","journal-title":"J\u00a0Allergy Clin Immunol Pract"},{"key":"10.1016\/j.jaip.2019.05.034_bib20","first-page":"1139","article-title":"Anaphylactic shock caused by intravenous sulfonamide application with fatal outcome [in German]","volume":"15","author":"Reichmann","year":"1960","journal-title":"Dtsch Gesundheitsw"},{"key":"10.1016\/j.jaip.2019.05.034_bib21","doi-asserted-by":"crossref","first-page":"56","DOI":"10.1111\/cod.12745","article-title":"Contact urticaria syndrome caused by sulfamethoxazole sodium contained in eye drops","volume":"77","author":"Fujiwara","year":"2017","journal-title":"Contact Dermatitis"},{"key":"10.1016\/j.jaip.2019.05.034_bib22","doi-asserted-by":"crossref","first-page":"510","DOI":"10.1046\/j.1365-2222.1998.00258.x","article-title":"Anaphylactic reactions associated with trimethoprim","volume":"28","author":"Bijl","year":"1998","journal-title":"Clin Exp Allergy"},{"key":"10.1016\/j.jaip.2019.05.034_bib23","doi-asserted-by":"crossref","first-page":"426","DOI":"10.1093\/clinids\/4.2.426","article-title":"Adverse reactions to trimethoprim-sulfamethoxazole in hospitalized patients","volume":"4","author":"Jick","year":"1982","journal-title":"Rev Infect Dis"},{"key":"10.1016\/j.jaip.2019.05.034_bib24","doi-asserted-by":"crossref","first-page":"114","DOI":"10.2174\/1574886311308020004","article-title":"A\u00a0comparison of adverse drug reactions between high- and standard-dose trimethoprim-sulfamethoxazole in the ambulatory setting","volume":"8","author":"Nguyen","year":"2013","journal-title":"Curr Drug Saf"},{"key":"10.1016\/j.jaip.2019.05.034_bib25","first-page":"284","article-title":"Cutaneous adverse reactions to sulfonamide antibiotics","volume":"29","author":"Chantachaeng","year":"2011","journal-title":"Asian Pac J Allergy Immunol"},{"key":"10.1016\/j.jaip.2019.05.034_bib26","first-page":"E9","article-title":"Sweet syndrome presenting with an unusual morphology","volume":"96","author":"Tam","year":"2015","journal-title":"Cutis"},{"key":"10.1016\/j.jaip.2019.05.034_bib27","doi-asserted-by":"crossref","first-page":"1159","DOI":"10.1111\/j.1365-4632.2011.05107.x","article-title":"Baboon syndrome\/SDRIFE due to sulfamethoxazole-trimethoprim","volume":"52","author":"Culav","year":"2013","journal-title":"Int J Dermatol"},{"key":"10.1016\/j.jaip.2019.05.034_bib28","doi-asserted-by":"crossref","first-page":"525","DOI":"10.1001\/archderm.1947.01520040094010","article-title":"Sulfonamide psoriasiform dermatitis","volume":"55","author":"Philpott","year":"1947","journal-title":"Arch Derm Syphilol"},{"key":"10.1016\/j.jaip.2019.05.034_bib29","first-page":"66","article-title":"Acute generalized exanthematous pustulosis due to sulfamethoxazol with positive lymphocyte transformation test (LTT)","volume":"13","author":"Anliker","year":"2003","journal-title":"J\u00a0Investig Allergol Clin Immunol"},{"key":"10.1016\/j.jaip.2019.05.034_bib30","article-title":"Trimethoprim-sulfamethoxazole-induced linear IgA bullous disease presenting as toxic epidermal necrolysis","volume":"23","author":"Baltazard","year":"2017","journal-title":"Dermatol Online J"},{"key":"10.1016\/j.jaip.2019.05.034_bib31","doi-asserted-by":"crossref","first-page":"1071","DOI":"10.1111\/bjd.12501","article-title":"Drug reaction with eosinophilia and systemic symptoms (DRESS): an original multisystem adverse drug reaction. Results from the prospective RegiSCAR study","volume":"169","author":"Kardaun","year":"2013","journal-title":"Br J Dermatol"},{"key":"10.1016\/j.jaip.2019.05.034_bib32","doi-asserted-by":"crossref","first-page":"35","DOI":"10.1038\/sj.jid.5701033","article-title":"Stevens-Johnson syndrome and toxic epidermal necrolysis: assessment of medication risks with emphasis on recently marketed drugs. The EuroSCAR-study","volume":"128","author":"Mockenhaupt","year":"2008","journal-title":"J\u00a0Invest Dermatol"},{"key":"10.1016\/j.jaip.2019.05.034_bib33","doi-asserted-by":"crossref","first-page":"1187","DOI":"10.1016\/j.jaip.2016.04.026","article-title":"A\u00a0comparative analysis between antibiotic- and nonantibiotic-associated delayed cutaneous adverse drug reactions","volume":"4","author":"Trubiano","year":"2016","journal-title":"J\u00a0Allergy Clin Immunol Pract"},{"key":"10.1016\/j.jaip.2019.05.034_bib34","doi-asserted-by":"crossref","first-page":"630","DOI":"10.1016\/j.jaad.2011.12.014","article-title":"Toxic epidermal necrolysis: five years of treatment experience from a burn unit","volume":"67","author":"Firoz","year":"2012","journal-title":"J\u00a0Am Acad Dermatol"},{"key":"10.1016\/j.jaip.2019.05.034_bib35","doi-asserted-by":"crossref","first-page":"428","DOI":"10.1002\/j.1875-9114.1995.tb04378.x","article-title":"A\u00a0large population-based follow-up study of trimethoprim-sulfamethoxazole, trimethoprim, and cephalexin for uncommon serious drug toxicity","volume":"15","author":"Jick","year":"1995","journal-title":"Pharmacotherapy"},{"key":"10.1016\/j.jaip.2019.05.034_bib36","doi-asserted-by":"crossref","first-page":"649","DOI":"10.1046\/j.1365-2125.1997.00590.x","article-title":"Hospitalization for serious blood and skin disorders following co-trimoxazole","volume":"43","author":"Myers","year":"1997","journal-title":"Br J Clin Pharmacol"},{"key":"10.1016\/j.jaip.2019.05.034_bib37","doi-asserted-by":"crossref","first-page":"1193","DOI":"10.1016\/j.jaad.2009.08.036","article-title":"Seasonal variation of Stevens-Johnson syndrome and toxic epidermal necrolysis associated with trimethoprim-sulfamethoxazole","volume":"64","author":"Kelly","year":"2011","journal-title":"J\u00a0Am Acad Dermatol"},{"key":"10.1016\/j.jaip.2019.05.034_bib38","doi-asserted-by":"crossref","first-page":"785","DOI":"10.1056\/NEJM196710122771503","article-title":"Sulfonamide hepatic injury. Review of the literature and report of a case due to sulfamethoxazole","volume":"277","author":"Dujovne","year":"1967","journal-title":"N\u00a0Engl J Med"},{"key":"10.1016\/j.jaip.2019.05.034_bib39","doi-asserted-by":"crossref","first-page":"1924","DOI":"10.1053\/j.gastro.2008.09.011","article-title":"Causes, clinical features, and outcomes from a prospective study of drug-induced liver injury in the United States","volume":"135","author":"Chalasani","year":"2008","journal-title":"Gastroenterology"},{"key":"10.1016\/j.jaip.2019.05.034_bib40","doi-asserted-by":"crossref","first-page":"482","DOI":"10.4103\/ijn.IJN_339_16","article-title":"Trimethoprim-sulfamethoxazole-induced hepatotoxicity in a renal transplant patient","volume":"27","author":"Slim","year":"2017","journal-title":"Indian J Nephrol"},{"key":"10.1016\/j.jaip.2019.05.034_bib41","first-page":"1577","article-title":"Fulminant liver failure and pancreatitis associated with the use of sulfamethoxazole-trimethoprim","volume":"84","author":"Alberti-Flor","year":"1989","journal-title":"Am J Gastroenterol"},{"key":"10.1016\/j.jaip.2019.05.034_bib42","doi-asserted-by":"crossref","first-page":"371","DOI":"10.1055\/s-2008-1063622","article-title":"Eosinophilic gastroenteritis as an allergic reaction to a trimethoprim-sulfonamide preparation [in German]","volume":"116","author":"Wienand","year":"1991","journal-title":"Dtsch Med Wochenschr"},{"key":"10.1016\/j.jaip.2019.05.034_bib43","doi-asserted-by":"crossref","first-page":"1271","DOI":"10.1093\/jac\/dks030","article-title":"Acute kidney injury associated with trimethoprim\/sulfamethoxazole","volume":"67","author":"Fraser","year":"2012","journal-title":"J\u00a0Antimicrob Chemother"},{"key":"10.1016\/j.jaip.2019.05.034_bib44","doi-asserted-by":"crossref","first-page":"520","DOI":"10.1016\/j.anai.2014.08.006","article-title":"Trimethoprim-sulfamethoxazole-induced aseptic meningitis-not just another sulfa allergy","volume":"113","author":"Bruner","year":"2014","journal-title":"Ann Allergy Asthma Immunol"},{"key":"10.1016\/j.jaip.2019.05.034_bib45","doi-asserted-by":"crossref","first-page":"1109","DOI":"10.1016\/S0140-6736(83)90627-X","article-title":"Complications of co-trimoxazole in treatment of AIDS-associated Pneumocystis carinii pneumonia in homosexual men","volume":"2","author":"Jaffe","year":"1983","journal-title":"Lancet"},{"key":"10.1016\/j.jaip.2019.05.034_bib46","doi-asserted-by":"crossref","first-page":"495","DOI":"10.7326\/0003-4819-100-4-495","article-title":"Adverse reactions to trimethoprim-sulfamethoxazole in patients with the acquired immunodeficiency syndrome","volume":"100","author":"Gordin","year":"1984","journal-title":"Ann Intern Med"},{"key":"10.1016\/j.jaip.2019.05.034_bib47","doi-asserted-by":"crossref","first-page":"40","DOI":"10.1067\/mjd.2002.120468","article-title":"Prospective evaluation of risk factors of cutaneous drug reactions to sulfonamides in patients with AIDS","volume":"47","author":"Eliaszewicz","year":"2002","journal-title":"J\u00a0Am Acad Dermatol"},{"key":"10.1016\/j.jaip.2019.05.034_bib48","doi-asserted-by":"crossref","first-page":"531","DOI":"10.2217\/pgs.09.6","article-title":"TNF, LTA, HSPA1L and HLA-DR gene polymorphisms in HIV-positive patients with hypersensitivity to cotrimoxazole","volume":"10","author":"Alfirevic","year":"2009","journal-title":"Pharmacogenomics"},{"key":"10.1016\/j.jaip.2019.05.034_bib49","doi-asserted-by":"crossref","first-page":"784","DOI":"10.1016\/0091-6749(91)90186-R","article-title":"Detection of human IgE to sulfamethoxazole by skin testing with sulfamethoxazoyl-poly-L-tyrosine","volume":"88","author":"Gruchalla","year":"1991","journal-title":"J\u00a0Allergy Clin Immunol"},{"key":"10.1016\/j.jaip.2019.05.034_bib50","doi-asserted-by":"crossref","first-page":"629","DOI":"10.1016\/S0091-6749(03)01783-4","article-title":"Nonirritating intradermal skin test concentrations for commonly prescribed antibiotics","volume":"112","author":"Empedrad","year":"2003","journal-title":"J\u00a0Allergy Clin Immunol"},{"key":"10.1016\/j.jaip.2019.05.034_bib51","doi-asserted-by":"crossref","first-page":"355","DOI":"10.1016\/S1081-1206(10)60037-3","article-title":"Management of adverse reactions to prophylactic trimethoprim-sulfamethoxazole in patients with human immunodeficiency virus infection","volume":"76","author":"Belchi-Hernandez","year":"1996","journal-title":"Ann Allergy Asthma Immunol"},{"key":"10.1016\/j.jaip.2019.05.034_bib52","doi-asserted-by":"crossref","first-page":"111","DOI":"10.1016\/S0163-4453(99)90078-6","article-title":"Desensitization to co-trimoxazole (trimethoprim-sulphamethoxazole) in HIV-infected patients: is patch testing a useful predictor of reaction?","volume":"38","author":"Gompels","year":"1999","journal-title":"J Infect"},{"key":"10.1016\/j.jaip.2019.05.034_bib53","doi-asserted-by":"crossref","first-page":"50","DOI":"10.1111\/j.1600-0536.2009.01553.x","article-title":"Flare-up of patch test of trimethoprim-sulfamethoxazole (co-trimoxazole) during oral desensitization","volume":"61","author":"Kardaun","year":"2009","journal-title":"Contact Dermatitis"},{"key":"10.1016\/j.jaip.2019.05.034_bib54","doi-asserted-by":"crossref","first-page":"258","DOI":"10.1111\/j.1600-0536.1998.tb05739.x","article-title":"Topical provocation in 31 cases of fixed drug eruption: change of causative drugs in 10 years","volume":"38","author":"Lee","year":"1998","journal-title":"Contact Dermatitis"},{"key":"10.1016\/j.jaip.2019.05.034_bib55","doi-asserted-by":"crossref","first-page":"185","DOI":"10.1111\/j.1600-0536.1999.tb06127.x","article-title":"Topical provocation in 27 cases of cotrimoxazole-induced fixed drug eruption","volume":"41","author":"Ozkaya-Bayazit","year":"1999","journal-title":"Contact Dermatitis"},{"key":"10.1016\/j.jaip.2019.05.034_bib56","doi-asserted-by":"crossref","first-page":"175","DOI":"10.1111\/j.1600-0536.1996.tb02339.x","article-title":"Patch testing in an unusual case of toxic epidermal necrolysis","volume":"35","author":"Klein","year":"1996","journal-title":"Contact Dermatitis"},{"key":"10.1016\/j.jaip.2019.05.034_bib57","doi-asserted-by":"crossref","first-page":"1103","DOI":"10.1111\/all.12886","article-title":"In\u00a0vitro tests for drug hypersensitivity reactions: an ENDA\/EAACI Drug Allergy Interest Group position paper","volume":"71","author":"Mayorga","year":"2016","journal-title":"Allergy"},{"key":"10.1016\/j.jaip.2019.05.034_bib58","doi-asserted-by":"crossref","first-page":"854","DOI":"10.1034\/j.1398-9995.2003.00279.x","article-title":"Drug provocation testing in the diagnosis of drug hypersensitivity reactions: general considerations","volume":"58","author":"Aberer","year":"2003","journal-title":"Allergy"},{"key":"10.1016\/j.jaip.2019.05.034_bib59","doi-asserted-by":"crossref","first-page":"844","DOI":"10.1111\/all.12161","article-title":"Desensitization in delayed drug hypersensitivity reactions\u2014an EAACI position paper of the Drug Allergy Interest Group","volume":"68","author":"Scherer","year":"2013","journal-title":"Allergy"},{"issue":"Pt 1","key":"10.1016\/j.jaip.2019.05.034_bib60","doi-asserted-by":"crossref","first-page":"1033","DOI":"10.1016\/S0091-6749(98)70343-4","article-title":"Six-hour trimethoprim-sulfamethoxazole-graded challenge in HIV-infected patients","volume":"102","author":"Demoly","year":"1998","journal-title":"J\u00a0Allergy Clin Immunol"},{"key":"10.1016\/j.jaip.2019.05.034_bib61","doi-asserted-by":"crossref","first-page":"148","DOI":"10.7326\/0003-4819-105-1-148","article-title":"Co-trimoxazole desensitization in bone marrow transplantation","volume":"105","author":"Hughes","year":"1986","journal-title":"Ann Intern Med"},{"key":"10.1016\/j.jaip.2019.05.034_bib62","doi-asserted-by":"crossref","first-page":"271","DOI":"10.1002\/mpo.10196","article-title":"Successful desensitization to trimethoprim-sulfamethoxazole after allogeneic haematopoietic stem cell transplantation: preliminary observations","volume":"40","author":"Soffritti","year":"2003","journal-title":"Med Pediatr Oncol"},{"key":"10.1016\/j.jaip.2019.05.034_bib63","doi-asserted-by":"crossref","first-page":"52","DOI":"10.1016\/j.jaip.2013.11.002","article-title":"Successful outpatient graded administration of trimethoprim-sulfamethoxazole in patients without HIV and with a history of sulfonamide adverse drug reaction","volume":"2","author":"Pyle","year":"2014","journal-title":"J\u00a0Allergy Clin Immunol Pract"},{"key":"10.1016\/j.jaip.2019.05.034_bib64","first-page":"309","article-title":"Desensitization to co-trimoxazole in a patient with fixed drug eruption","volume":"18","author":"Patriarca","year":"2008","journal-title":"J\u00a0Investig Allergol Clin Immunol"},{"key":"10.1016\/j.jaip.2019.05.034_bib65","doi-asserted-by":"crossref","first-page":"1480","DOI":"10.1086\/516995","article-title":"Successful desensitization of two patients who previously developed Stevens-Johnson syndrome while receiving trimethoprim-sulfamethoxazole","volume":"25","author":"Douglas","year":"1997","journal-title":"Clin Infect Dis"},{"key":"10.1016\/j.jaip.2019.05.034_bib66","doi-asserted-by":"crossref","first-page":"849","DOI":"10.1093\/clinids\/20.4.849","article-title":"Rapid oral desensitization to trimethoprim-sulfamethoxazole (TMP-SMZ): use in prophylaxis for Pneumocystis carinii pneumonia in patients with AIDS who were previously intolerant to TMP-SMZ","volume":"20","author":"Gluckstein","year":"1995","journal-title":"Clin Infect Dis"},{"key":"10.1016\/j.jaip.2019.05.034_bib67","doi-asserted-by":"crossref","first-page":"45","DOI":"10.1016\/S0753-3322(00)88640-0","article-title":"The effectiveness of desensitization versus rechallenge treatment in HIV-positive patients with previous hypersensitivity to TMP-SMX: a randomized multicentric study. C.I.S.A.I. Group","volume":"54","author":"Bonfanti","year":"2000","journal-title":"Biomed Pharmacother"},{"key":"10.1016\/j.jaip.2019.05.034_bib68","doi-asserted-by":"crossref","first-page":"276","DOI":"10.1590\/S1413-86702002000600002","article-title":"A\u00a0randomized, pilot trial comparing full versus escalating dose regimens for the desensitization of AIDS patients allergic to sulfonamides","volume":"6","author":"Straatmann","year":"2002","journal-title":"Braz J Infect Dis"},{"key":"10.1016\/j.jaip.2019.05.034_bib69","doi-asserted-by":"crossref","first-page":"992","DOI":"10.1086\/323353","article-title":"Trimethoprim-sulfamethoxazole (TMP-SMZ) dose escalation versus direct rechallenge for Pneumocystis Carinii pneumonia prophylaxis in human immunodeficiency virus-infected patients with previous adverse reaction to TMP-SMZ","volume":"184","author":"Leoung","year":"2001","journal-title":"J Infect Dis"},{"issue":"2","key":"10.1016\/j.jaip.2019.05.034_bib70","first-page":"CD005646","article-title":"Cotrimoxazole for prophylaxis or treatment of opportunistic infections of HIV\/AIDS in patients with previous history of hypersensitivity to cotrimoxazole","author":"Lin","year":"2007","journal-title":"Cochrane Database Syst Rev"},{"key":"10.1016\/j.jaip.2019.05.034_bib71","doi-asserted-by":"crossref","first-page":"52","DOI":"10.1016\/0140-6736(90)91563-P","article-title":"\"Treating through\" hypersensitivity to co-trimoxazole in AIDS patients","volume":"336","author":"Putterman","year":"1990","journal-title":"Lancet"}],"container-title":["The Journal of Allergy and Clinical Immunology: In Practice"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S221321981930491X?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S221321981930491X?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,11,1]],"date-time":"2025-11-01T05:20:48Z","timestamp":1761974448000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S221321981930491X"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,9]]},"references-count":71,"journal-issue":{"issue":"7","published-print":{"date-parts":[[2019,9]]}},"alternative-id":["S221321981930491X"],"URL":"https:\/\/doi.org\/10.1016\/j.jaip.2019.05.034","relation":{},"ISSN":["2213-2198"],"issn-type":[{"value":"2213-2198","type":"print"}],"subject":[],"published":{"date-parts":[[2019,9]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Sulfonamide Hypersensitivity: Fact and Fiction","name":"articletitle","label":"Article Title"},{"value":"The Journal of Allergy and Clinical Immunology: In Practice","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jaip.2019.05.034","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2019 American Academy of Allergy, Asthma & Immunology","name":"copyright","label":"Copyright"}]}}